P/E ratio for Regis Healthcare (REG.AX)
P/E ratio at the end of 2023: -21.2
According to Regis Healthcare's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -61.4514. At the end of 2023 the company had a P/E ratio of -21.2.
P/E ratio history for Regis Healthcare from 2015 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2023 | -21.2 | 71.64% |
| 2022 | -12.3 | -152.53% |
| 2021 | 23.5 | -75.55% |
| 2020 | 96.1 | 604.8% |
| 2019 | 13.6 | -8.09% |
| 2018 | 14.8 | -2.21% |
| 2017 | 15.2 | -38.39% |
| 2016 | 24.6 | 32.39% |
| 2015 | 18.6 |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.